Hatteras Venture Advisors Iii, Llc - Net Worth and Insider Trading
Hatteras Venture Advisors Iii, Llc Net Worth
The estimated net worth of Hatteras Venture Advisors Iii, Llc is at least $4 Million dollars as of 2024-06-10. Hatteras Venture Advisors Iii, Llc is the of Clearside Biomedical Inc and owns about 3,521,916 shares of Clearside Biomedical Inc (CLSD) stock worth over $4 Million. Hatteras Venture Advisors Iii, Llc is also the 10% Owner of PhaseBio Pharmaceuticals Inc and owns about 2,458,049 shares of PhaseBio Pharmaceuticals Inc (PHASQ) stock worth over $246. Details can be seen in Hatteras Venture Advisors Iii, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hatteras Venture Advisors Iii, Llc has not made any transactions after 2018-10-22 and currently still holds the listed stock(s).
Transaction Summary of Hatteras Venture Advisors Iii, Llc
Hatteras Venture Advisors Iii, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hatteras Venture Advisors Iii, Llc owns 2 companies in total, including PhaseBio Pharmaceuticals Inc (PHASQ) , and Clearside Biomedical Inc (CLSD) .
Insider Ownership Summary of Hatteras Venture Advisors Iii, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PHASQ | PhaseBio Pharmaceuticals Inc | 2018-10-22 | 10 percent owner |
| CLSD | Clearside Biomedical Inc | 2017-01-19 | 10 percent owner |
Hatteras Venture Advisors Iii, Llc Latest Holdings Summary
Hatteras Venture Advisors Iii, Llc currently owns a total of 2 stocks. Among these stocks, Hatteras Venture Advisors Iii, Llc owns 3,521,916 shares of Clearside Biomedical Inc (CLSD) as of January 19, 2017, with a value of $4 Million and a weighting of 99.99%. Hatteras Venture Advisors Iii, Llc also owns 2,458,049 shares of PhaseBio Pharmaceuticals Inc (PHASQ) as of October 22, 2018, with a value of $246 and a weighting of 0.01%.
Latest Holdings of Hatteras Venture Advisors Iii, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLSD | Clearside Biomedical Inc | 2017-01-19 | 3,521,916 | 1.22 | 4,296,738 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 2018-10-22 | 2,458,049 | 0.00 | 246 |
Holding Weightings of Hatteras Venture Advisors Iii, Llc
Hatteras Venture Advisors Iii, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Hatteras Venture Advisors Iii, Llc has made a total of 0 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years. The most-recent trade in Clearside Biomedical Inc is the sale of 25,301 shares on January 19, 2017, which brought Hatteras Venture Advisors Iii, Llc around $218,348.
According to the SEC Form 4 filings, Hatteras Venture Advisors Iii, Llc has made a total of 0 transactions in PhaseBio Pharmaceuticals Inc (PHASQ) over the past 5 years. The most-recent trade in PhaseBio Pharmaceuticals Inc is the acquisition of 300,000 shares on October 22, 2018, which cost Hatteras Venture Advisors Iii, Llc around $2 Million.
Insider Trading History of Hatteras Venture Advisors Iii, Llc
- 1
Hatteras Venture Advisors Iii, Llc Trading Performance
GuruFocus tracks the stock performance after each of Hatteras Venture Advisors Iii, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hatteras Venture Advisors Iii, Llc is -3.53%. GuruFocus also compares Hatteras Venture Advisors Iii, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hatteras Venture Advisors Iii, Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hatteras Venture Advisors Iii, Llc's insider trading performs compared to the benchmark.
Performance of Hatteras Venture Advisors Iii, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -23.54 | | | | | |
| Relative Return to S&P 500(%) | -21.29 | | | | | |
Hatteras Venture Advisors Iii, Llc Ownership Network
Hatteras Venture Advisors Iii, Llc Owned Company Details
What does PhaseBio Pharmaceuticals Inc do?
Who are the key executives at PhaseBio Pharmaceuticals Inc?
Hatteras Venture Advisors Iii, Llc is the 10 percent owner of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .
PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
PhaseBio Pharmaceuticals Inc Insider Transactions
Hatteras Venture Advisors Iii, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Hatteras Venture Advisors Iii, Llc. You might contact Hatteras Venture Advisors Iii, Llc via mailing address: 280 S. Mangum Street, Suite 350, Durham Nc 27701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
